Hydroxyquinolone derivatives compounds which have pharmaceutical utility
申请人:Merck Sharpe & Dohme Ltd.
公开号:US05348962A1
公开(公告)日:1994-09-20
This present invention relates to a class of 4-hydroxy-2-(1H)-quinolones which are substituted in the 3-position by an optionally substituted aryl substituent. These compounds are selective non-competitive antagonists of N-methyl-D-aspartate (NMDA) receptors.